wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36429516-15E0513B-0EF9-4129-85D0-853A6311A331
Q36429516-15E0513B-0EF9-4129-85D0-853A6311A331
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36429516-15E0513B-0EF9-4129-85D0-853A6311A331
Targeting HER1/EGFR in cancer therapy: experience with erlotinib.
P2860
Q36429516-15E0513B-0EF9-4129-85D0-853A6311A331
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36429516-15E0513B-0EF9-4129-85D0-853A6311A331
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
005ae894de7112aeb73a388f4a1c529d1b233de8
P2860
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lun